These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2624913)

  • 1. Ocular complications of a topical methylene blue-vasoconstrictor-anesthetic preparation.
    Brownstein S; Liszauer AD; Jackson WB
    Can J Ophthalmol; 1989 Dec; 24(7):317-24. PubMed ID: 2624913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular tattooing caused by abuse of a methylene blue eye-wash].
    Pasticier-Florquin A; Boski LS; Morax S; Forest A
    Bull Soc Ophtalmol Fr; 1977 Feb; 77(2):147-51. PubMed ID: 597987
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and chronic conjunctivitis due to over-the-counter ophthalmic decongestants.
    Soparkar CN; Wilhelmus KR; Koch DD; Wallace GW; Jones DB
    Arch Ophthalmol; 1997 Jan; 115(1):34-8. PubMed ID: 9006422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [. Oсumethyl in the treatment of allergic diseases of eyelids and conjunctiva].
    Marchenko NR
    Vestn Oftalmol; 2016; 132(5):81-85. PubMed ID: 27911431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV; Udell IJ
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and absence of rebound vasodilation following topical ocular decongestant usage.
    Abelson MB; Butrus SI; Weston JH; Rosner B
    Ophthalmology; 1984 Nov; 91(11):1364-7. PubMed ID: 6514304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abuse of vasoconstrictive eyedrops mimicking an ocular pemphigoid.
    Tappeiner C; Sarra GM; Abegg M
    Eur J Ophthalmol; 2009; 19(1):129-32. PubMed ID: 19123160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival goblet cell response to vasoconstrictor use.
    Shellans S; Rich LF; Louiselle I
    J Ocul Pharmacol; 1989; 5(3):217-20. PubMed ID: 2625617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study.
    Wilson FM
    Trans Am Ophthalmol Soc; 1983; 81():854-965. PubMed ID: 6676985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conjunctival alterations by sympathomimetic drugs (author's transl)].
    Lisch K
    Klin Monbl Augenheilkd; 1978 Sep; 173(3):404-6. PubMed ID: 750716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal opacities secondary to topical naphazoline and antazoline (Albalon-A).
    Herman DC; Bartley GB
    Am J Ophthalmol; 1987 Jan; 103(1):110-1. PubMed ID: 3799780
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjunctival temperature: a measure of ocular decongestant and anti-inflammatory activity.
    Salem H; Dunn BJ; Loux JJ
    Ann Ophthalmol; 1975 Jun; 7(6):819-24. PubMed ID: 1147509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H; Ohashi Y; Takamura E
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo neurological deterioration due to naphazoline eye ointment.
    Martens PR
    Anaesth Intensive Care; 1990 May; 18(2):269. PubMed ID: 2368908
    [No Abstract]   [Full Text] [Related]  

  • 16. Corneal complications of topical anesthetic abuse.
    Willis WE; Laibson PR
    Can J Ophthalmol; 1970 Jul; 5(3):239-43. PubMed ID: 5472832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ocular pseudopemphigoid after topical drug administration].
    Anders N; Wollensak J
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):61-4. PubMed ID: 7967407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: unilateral mydriasis from topical Opcon-A and soft contact lens.
    Williams TL; Williams AJ; Enzenauer RW
    Aviat Space Environ Med; 1997 Nov; 68(11):1035-7. PubMed ID: 9383505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural study of argyrosis of the cornea and conjunctiva.
    Hanna C; Fraunfelder FT; Sanchez J
    Arch Ophthalmol; 1974 Jul; 92(1):18-22. PubMed ID: 4835972
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R; Mauracher E
    Pharmatherapeutica; 1983; 3(6):376-81. PubMed ID: 6353428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.